Ma. Hermie Culeen F. Barapon
PAIN
-The means by which the body is made
aware of the presence of tissue
damage
There are two components of pain:
• Perception is the process by which
pain is recognized by the brain
• Reaction is any involuntary act
occurring in response to a stimulus
causing sharp pain
Nonopioid (nonnarcotic)
Analgesics
• relieve pain with only a minor alteration of
consciousness
• safer than opioids, produce fewer side
effects, and are not addicting
• act principally at the peripheral nerve
endings
• inhibit the synthesis of prostaglandins,
which occurs at sites of tissue inflammation
and produce their analgesic effects
peripherally and their antipyretic effect
centrally
CLINICAL
CONSIDERATIONS:
1. Nonopioid analgesics are more
effective if given before the pain
and inflammation associated with
prostaglandin synthesis occur.
2. Nonopioid analgesics are not
completely effective because they
do not affect the formation of
primary pain mediators.
Principal Pharmacologic Actions:
1. Analgesia
2. Antipyresis
3. Antiinflammatory action
• Of these actions the salicylates and
NSAIAs exhibit all three in
therapeutically useful amounts, and
acetaminophen exhibits only analgesia
and antipyresis.
Salicylates
- Came from the extracts of willow bark
containing the bitter glycoside salicin
1. Acetylsalicylic acid (Aspirin, Bayer,
A.S.A.)
2. Sodium salicylate (Uracel)
3. Magnesium salicylate (Mobidin, Doan’s
pills)
4. Salsalate (Disalcid, Monogesic)
5. Salicylamide (Uromide)
6. Diflunisal (Doloboid)
7. Methylsalicylate (oil of wintergreen)
8. Salicylic acid (Salacid, Freezone)
Acetysalicylic acid (Aspirin)
• most widely employed drug in medical and
dental practice
• Described as the prototype salicylate
Ascriptin Ecotrin
Aspro Entrophen
Bayer Halfprin
Bex Novasen
Bufferin Solprin
Disprin Spren
Uses:
1. Treatment of mild to moderate pain
2. In control of fever
3. Treatment of rheumatic fever and
arthritis
4. Treatment of thromboembolic disorders
5. Treatment of transient ischemic attacks
in men
6. Treatment in post-MI
Mechanism of Action
• The inflammatory stimulus activates
or releases a phospholipase, which
cleaves the essential fatty acid
(arachidonic acid) from membrane
lecithin, thereby making it available
for prostaglandin synthesis by the
enzyme cyclooxygenase. Aspirin-like
drugs inhibit the cyclooxygenase by
acytelating a serine at its site of
action.
Pharmacologic effects:
1. Analgesia
The inhibition of prostaglandin synthesis
by aspirin-like drugs leads to analgesia by
decreasing the sensitivity of pain fibers
to the presence of pain-producing
substances.
2. Antipyresis
The antipyretic action of aspirin-like
drugs results from inhibition of
prostaglandin synthesis in the
hypothalamus.
3. Anti-inflammatory effects
The inhibition of prostaglandin synthesis
leads to decreased redness and swelling
of the inflamed area.
4. Uricosuric effect
Large doses of aspirin (over 5gm/24 hr)
increase uric acid secretion and decrease
plasma urate concentrations. Smaller
doses of aspirin (1-2gm/24hr) may
decrease the secretion of uric acid and
elevate the plasma urate concentration.
5. Platelet effects
At therapeutic doses, aspirin prolongs
bleeding time. The mechanism of action is
related to acytelation of platelet
cyclooxygenase and subsequent reduction
in thromboxane A2 (TXA2), a potent
aggregating substance. This effect on the
platelet is irreversible and lasts for the
life of the platelets exposed.
• Aspirin has been shown to be effective in a few
selected trials in males, such as in prevention of
myocardial infection with unstable angina and prevention
of stroke in patients with transient cerebral ischemia.
Adverse effects:
1. Gastrointestinal effects
- Dyspepsia
- Nausea and vomiting
- GIT bleeding
- Ulcer
These effects are produced in 2 ways:
- Local irritation
- Inhibition of prostaglandin
GIT effects can be reduced through:
1. Ingestion with food or with a full glass
of milk or water
2. In solution
3. Ingestion of liquid antacid
2. Hypoprothrombinemia
- can result after long-term use
- Aspirin is known to prolong prothrombin
time and inhibit platelet function
3. Thyroid-Stimulating Effect
- Results from long-term aspirin
consumption
- Elevated free thyroid hormone in the
blood
4. Metabolic Effect
- Aspirin uncouples oxidative
phosphorylation and reduces
lipogenesis
- Affects CHO metabolism so that the
blood sugar may be elevated or lowered
5. Hepatic and Renal Effects
- hepatotoxicity
- Reye’s syndrome
- Papillary necrosis and interstititial
nephritis
6. Effects on Pregnancy
- Pregnancy Risk Category: C
- Salicylates readily cross placental
barrier and are excreted in breast milk
- Prolonged gestation, delayed
parturition, increased risk of
hemorrhage in mother and newborn,
increased risk of stillbirth or neonatal
death, and decreased birthweight
7. Hypersensitivity
- Results from inhibition of
cyclooxygenase
- SRS-A symptoms include
bronchospasm, angioneurotic edema,
rhinitis, urticaria, wheezing,
hypotensive shock, abdominal cramps
and nasal polyps
8. Glucose-6-Phosphate Dehydrogenase
Deficiency
- A common inborn error of metabolism
- Symptoms of hemolysis includes
abdominal or back pain, anemia,
hemoglobinuria
Toxicity
• Salicylism – mild toxic reaction produced
by salicylates
• Signs and Symptoms:
1. Tinnitus
2. Headache
3. Nausea and vomiting
4. Dizziness
5. Dimness of vision
• The lethal adult dose of aspirin is
between 10 and 30 gm (30 to 100 of the
5-grain tablets)
Severe acidosis and electrolyte
imbalance are usually the causes of
death resulting from:
1. Depression of the respiratory
center (CO2 accumulation)
2. Renal impairment from dehydration
and hypotension (inorganic &
metabolic acids accumulate)
3. Impaired CHO metabolism that
increases the production of
metabolic acids
When aspirin is prescribed for a child,
one should ensure that:
1. The dosage is accurately
determined
2. Adequate fluid intake is maintained
3. The parent is cognizant of the
dangers of poisoning
4. The child does not have chicken pox
or flu.
Treatment:
1. By inducing emesis, gastric lavage, or by
the administration of activated charcoal.
2. Severe toxic reaction require immediate
hospitalization and the use of IV fluids to
correct acidosis and electrolyte imbalance
3. Bathing in tepid water and IV fluid must
be promptly administered in case of
hyperthermia and dehydration.
4. Alkaline diuresis should be maintained by
the administration of sodium bicarbonate
5. Hypoglycemia and hypokalemia are
treated symptomatically.
DRUG INTERACTIONS
1. Warfarin (Coumadin)
- oral anticoagulants
- aspirin displaces warfarin from
plasma protein binding sites which
increases active warfarin in the
blood and amplifies its toxic effect
- administering salicylates to
patients can increase prothrombin
time and promote GIT bleeding and
hemorrhage
2. Probenecid & Sulfinpyrazone
- used in treatment of gout
- aspirin has been reported to
precipitate an acute attack of gout
3. Sulfonylureas
- used in the treatment of adult-
onset diabetes mellitus
- Aspirins may enhance the
hypoglycemic response to
sulfonylureas
4. Methotrexate
- used as a cancer chemotherapy
agent or in the treatment of
psoriasis
- Methotrexate can be displaced
from its plasma protein binding
sites, leading to an increased
concentration of free methotrexate
Administration, Absorption &
Metabolism
- Aspirin is almost always administered
orally
- It is rapidly absorbed, partly from
the stomach but mainly from the
small intestine
- Once absorbed, aspirin is rapidly
hydrolyzed in the plasma to salicylic
acid which becomes unevenly
distributed throughout the body.
Administration, Absorption &
Metabolism
- Relatively high concentration are
found in the lungs, liver, saliva and
kidney; lower levels attained in the
muscle and brain
- Salicylates are excreted through
urine. Very little salicylate is
excreted in the feces
Dosages:
Arthritis
Adult: PO 2.6-5.2 g/day in divided doses q4-
6h
Child: PO 90-130 mg/kg/day in divided doses
q4-6h
Pain/fever
Adult: PO/REC 325-650 mg q4h prn, not to
exceed 4 g/day
Child: PO/REC 40-100 mg/kg/day in divided
doses q4-6h prn
Dosages:
Thromboembolic disorders
Adult: PO 325-650 mg/day or bid
Pain/fever
Adult: PO 650 mg bid or 325 mg qid; lower
daily doses of 160-325 mg have been used
as well
Preparations:
1. Regular aspirin
2. Enteric-coated aspirin
3. Sustained-release aspirin
4. Combinations
a. With antacid-buffering agent
b.With another analgesic
c. With sedatives or antihistamines
d.With caffeine
Diflunisal (Dolobid)
- long-acting NSAIA salicylate
- Food decrease the rate but not the
extent of absorption
- Half-life is 8-12 hours; onset 15-30
min; peak 2-3 hr
- Metabolized by the liver and
excreted via the kidney
- Excreted in breast milk, crosses
placenta
Dosage:
Pain/fever
Adult: PO loading dose 1 g then
500-1000 mg/day in 2
divided doses, q12h, not to
exceed 1500 mg/day
Adverse effects
GI: Nausea, anorexia, vomiting, bleeding,
diarrhea, heartburn, anorexia
CNS: stimulation, drowsiness, dizziness,
confusion, convulsion, headache, flushing,
hallucinations, coma
CV: rapid pulse, pulmonary edema
INTEG: rash, urticaria, bruising
ORAL: Dry mouth
HEMA: thrombocytopenia, agranulocytosis,
hemolytic anemia, increased pro-time
RESP: wheezing, hyperpnea
ENDO: Hypoglycemia, hyponatremia,
hypokalemia
Contraindications
• Hypersensitivity to salicylates
• Bleeding disorders
• Children <3 yr
• Vit.K deficiency
Precautions
• Anemia, hepatic disease, renal
disease, Hodgkin’s disease,
pregnancy category C, lactation
Drug Interactions
GI ulceration, bleeding: aspirin,
steroids, alcohol, indomethacin and
other NSAIDs
Hepatotoxicity, Nephrotoxicity:
acetaminophen (prolonged use)
Mechanism of Action
• NSAIAs inhibit the enzyme
cyclooxygenase, resulting in a
reduction in the formation of
prostaglandin precursors and
thromboxanes from arachidonic acid.
Chemical classifications:
1. Propionic Acid Derivatives
(Ibuprofen, Fenoprofen, Suprofen,
Naproxen, Naproxen sodium, Ketoprofen,
Benoxaprofen)
2. Acetic Acid Derivatives
(Indomethacin, Sulindac, Tolmetin)
3. Fenamic Acid Derivatives
(Meclofenemate, Mefenamic acid)
4. Pyrazolones (Phenylbutazone,
Oxyphenbutazone)
5. Oxicams (Piroxicam)
6. Salicylates (Diflunisal)
Pharmacokinetics:
• The NSAIAs peak in usually 1 to 2
hours
• They are metabolized in the liver
and excreted by the kidney.
• Fecal excretion occurs with fenamic
acids, piroxicam, sulindac, and
tolmetin.
• Food can reduce the rate of
absorption but oral antacids have
minimal or no effect on the rate of
absorption
Uses:
• Osteoarthritis, rheumatoid
arthritis, gouty arthritis
• Fever
• Dysmenorrhea
• pain
Pharmacologic effects:
1. Analgesic
2. Antipyretic
3. Antiinflammatory
4. Antigout
5. Dysmenorrhea
Adverse effects:
1. GIT effects
- pain
- bleeding leading to tarry
stools
- irritation
- ulceration
Adverse effects:
2. Renal effects
- renal failure
- cystitis
- increased incidence of UTI
- decreased renal blood flow
and glomerular filtration rate
in patients with kidney disease
Adverse effects:
3. CNS effects
- sedation
- dizziness
- confusion
- mental depression
- headache
- vertigo
- convulsions
Adverse effects:
4. Blood Clotting
- inhibition of platelet
aggregation remains only as long
as the drug is present in the
blood
5. Other effects
- muscle weakness, ringing ears,
blurred vision
- ulcerative stomatitis, gingival
ulceration
Adverse effects:
6. Hypersensitivity
- hives or itching
- angioneuretic edema
- chills and fever
- Steven Johnson syndrome
- exfoliative dermatitis
- anaphylactoid reactions during
bronchospasm
Adverse effects:
7. Pregnancy and Nursing
- prolonged gestation
- delayed parturition
- dystocia or premature closure
of the ductus arteriosus
- most NSAIDs are exreted in
breastmilk; piroxicam has been
shown to inhibit lactation
Contraindications:
• Asthma
• Cardiovascular diseases with fluid
retention
• Coagulopathies
• Peptic ulcer
• Ulcerative colitis
• Renal function impairment
• Hypersensitivity
• Geriatric patients
Ibuprofen
• The oldest member of the NSAIAs
and has the most clinical experience
• Rapidly absorbed orally, and food
decreases absorption, antacids have
no effect
• Undergoes hepatic metabolism end
excreted by the kidney
• Peak=1-2 hr; Half-life=2-4 hr;
Duration=4-6 hr
Uses:
• Rheumatoid arthritis, osteoarthritis
• Primary dysmenorrhea
• Gout
• Mild-to-moderate pain
• fever
Adverse effects
Oral: Dry mouth, bleeding, stomatitis
GI: Nausea, anorexia, vomiting, diarrhea,
jaundice, cholestatic hepatitis,
constipation, flatulence, peptic ulcer
CNS: Dizziness, drowsiness, fatigue,
tremors, confusion, insomnia, anxiety,
depression
CV: tachycardia, peripheral edema,
palpitation, dysrhythmias
GU: Nephrotoxicity: dysuria, hematuria,
oliguria, azotemia
HEMA: Blood dyscrasias
Contraindications
• Hypersensitivity
• Asthma
• Severe renal disease
• Severe hepatic disease
Precautions
• Pregnancy category not established,
lactation, children, bleeding
disorders, GI disorders, cardiac
disorders, hypersensitivity to other
antiinflammatory agents
Drug Interactions
GI ulceration, bleeding: aspirin,
alcohol, corticosteroids
Decreased action of ibuprofen:
salicylates
Nephrotoxicity: acetaminophen
Risk of increased effects: oral
anticoagulants, oral antidiabetics,
lithium, methotrexate
Decreased antihypertensive effects
of: diuretics, B-adrenergic blocker,
ACE inhibitors
Mefenamic acid
• Peak=2 hr; half-life=3-3 ½ hr
• Metabolized in liver, excreted in
urine
• Excreted in breastmilk
• Uses include mild-to-moderate pain,
dysmenorrhea, inflammatory disease
Adverse effects
GI: Nausea, anorexia, vomiting, diarrhea,
jaundice, cholestatic hepatitis,
constipation, flatulence, cramps, peptic
ulcer
CNS: Dizziness, drowsiness, fatigue,
tremors, confusion, insomnia, anxiety,
depression
CV: tachycardia, peripheral edema,
palpitation, dysrhythmias
INTEG: purpura, rash, pruritus, sweating
GU: Nephrotoxicity: dysuria, hematuria,
oliguria, azotemia
HEMA: Blood dyscrasias
Contraindications
• Hypersensitivity
• Asthma
• Severe renal disease
• Severe hepatic disease
Precautions
• Pregnancy category C (avoid
prescribing for dental use in last
trimester), lactation, children,
bleeding disorders, GI disorders,
cardiac disorders, hypersensitivity
to other antiinflammatory agents
Drug Interactions
GI ulceration, bleeding: aspirin,
alcohol, corticosteroids
Nephrotoxicity: acetaminophen
Risk of increased effects: oral
anticoagulants, oral antidiabetics,
lithium, methotrexate
Decreased antihypertensive effects
of: diuretics
Acetaminophen (Paracetamol;
N-acetyl paraaminophenol)
• Para-aminophenol derivative from
acetanilid
• Metabolized in liver, excreted by
the kidneys
• Crosses the placenta and is also
found in breast milk
• Rapidly and completely absorbed in
the GIT: onset 10-30 min, peak ½-
2hr, duration 4-6 hr, half-life 1-3 hr
Uses:
• Mild-to-moderate pain (inhibition
of prostaglandin synthesis in the
CNS)
• Fever
Advantages:
1. Therapeutic doses have no effect on
cardiovascular and respiratory
system.
2. It does not produce gastric
bleeding.
3. It does not affect platelet
adhesiveness or affect uric acid
excretion.
4. It enhances water transport in
kidney.
Adverse effects:
1. Hepatic necrosis
- may occur in adults after ingestion
of a single dose of 10-15 gm
acetaminophen
- symptoms include N & V, anorexia,
and abdominal pain
Treatment:
1. Ingestion of gastric lavage
2. Administration of activated
charcoal and magnesium or sodium
sulfate solution
3. Administration of N-acetylcysteine
to reduce or prevent liver damage
4. Hemodialysis or hemoperfusion may
be used if oral acetylcysteine does
not improve the patient
Adverse effects:
2. Nephrotoxicity
- associated with long-term
consumption
- primary lesion appears to be a
papillary necrosis with secondary
interstitial nephritis
Contraindications
• Hypersensitivity
Precautions
• Anemia
• Hepatic disease
• Renal disease
• Chronic alcoholism
• Pregnancy category B
Drug Interactions
Decreased effects of acetaminophen:
barbiturates
Nephrotoxicity: NSAIDs, salicylates
(chronic hig dose concurrent use)
Buffered acetaminophen: decreased
absorption of tetracycline
Increased bleeding (Chronic, high
doses over 2g/day): oral
anticoagulants
References:
• Gage, Tommy W. Mosby’s Dental
Drug Reference.Mosby-Year Book,
Inc. 1994.
• Holroyd, Sam V. Clinical
Pharmacology in Dental Practice.4th
ed. The C.V. Mosby Company. 1988.

Nonopioid analgesics

  • 1.
  • 2.
    PAIN -The means bywhich the body is made aware of the presence of tissue damage There are two components of pain: • Perception is the process by which pain is recognized by the brain • Reaction is any involuntary act occurring in response to a stimulus causing sharp pain
  • 3.
    Nonopioid (nonnarcotic) Analgesics • relievepain with only a minor alteration of consciousness • safer than opioids, produce fewer side effects, and are not addicting • act principally at the peripheral nerve endings • inhibit the synthesis of prostaglandins, which occurs at sites of tissue inflammation and produce their analgesic effects peripherally and their antipyretic effect centrally
  • 4.
    CLINICAL CONSIDERATIONS: 1. Nonopioid analgesicsare more effective if given before the pain and inflammation associated with prostaglandin synthesis occur. 2. Nonopioid analgesics are not completely effective because they do not affect the formation of primary pain mediators.
  • 5.
    Principal Pharmacologic Actions: 1.Analgesia 2. Antipyresis 3. Antiinflammatory action • Of these actions the salicylates and NSAIAs exhibit all three in therapeutically useful amounts, and acetaminophen exhibits only analgesia and antipyresis.
  • 7.
    Salicylates - Came fromthe extracts of willow bark containing the bitter glycoside salicin 1. Acetylsalicylic acid (Aspirin, Bayer, A.S.A.) 2. Sodium salicylate (Uracel) 3. Magnesium salicylate (Mobidin, Doan’s pills) 4. Salsalate (Disalcid, Monogesic) 5. Salicylamide (Uromide) 6. Diflunisal (Doloboid) 7. Methylsalicylate (oil of wintergreen) 8. Salicylic acid (Salacid, Freezone)
  • 8.
    Acetysalicylic acid (Aspirin) •most widely employed drug in medical and dental practice • Described as the prototype salicylate Ascriptin Ecotrin Aspro Entrophen Bayer Halfprin Bex Novasen Bufferin Solprin Disprin Spren
  • 9.
    Uses: 1. Treatment ofmild to moderate pain 2. In control of fever 3. Treatment of rheumatic fever and arthritis 4. Treatment of thromboembolic disorders 5. Treatment of transient ischemic attacks in men 6. Treatment in post-MI
  • 10.
    Mechanism of Action •The inflammatory stimulus activates or releases a phospholipase, which cleaves the essential fatty acid (arachidonic acid) from membrane lecithin, thereby making it available for prostaglandin synthesis by the enzyme cyclooxygenase. Aspirin-like drugs inhibit the cyclooxygenase by acytelating a serine at its site of action.
  • 11.
    Pharmacologic effects: 1. Analgesia Theinhibition of prostaglandin synthesis by aspirin-like drugs leads to analgesia by decreasing the sensitivity of pain fibers to the presence of pain-producing substances. 2. Antipyresis The antipyretic action of aspirin-like drugs results from inhibition of prostaglandin synthesis in the hypothalamus.
  • 12.
    3. Anti-inflammatory effects Theinhibition of prostaglandin synthesis leads to decreased redness and swelling of the inflamed area. 4. Uricosuric effect Large doses of aspirin (over 5gm/24 hr) increase uric acid secretion and decrease plasma urate concentrations. Smaller doses of aspirin (1-2gm/24hr) may decrease the secretion of uric acid and elevate the plasma urate concentration.
  • 13.
    5. Platelet effects Attherapeutic doses, aspirin prolongs bleeding time. The mechanism of action is related to acytelation of platelet cyclooxygenase and subsequent reduction in thromboxane A2 (TXA2), a potent aggregating substance. This effect on the platelet is irreversible and lasts for the life of the platelets exposed. • Aspirin has been shown to be effective in a few selected trials in males, such as in prevention of myocardial infection with unstable angina and prevention of stroke in patients with transient cerebral ischemia.
  • 14.
    Adverse effects: 1. Gastrointestinaleffects - Dyspepsia - Nausea and vomiting - GIT bleeding - Ulcer These effects are produced in 2 ways: - Local irritation - Inhibition of prostaglandin
  • 15.
    GIT effects canbe reduced through: 1. Ingestion with food or with a full glass of milk or water 2. In solution 3. Ingestion of liquid antacid
  • 16.
    2. Hypoprothrombinemia - canresult after long-term use - Aspirin is known to prolong prothrombin time and inhibit platelet function 3. Thyroid-Stimulating Effect - Results from long-term aspirin consumption - Elevated free thyroid hormone in the blood
  • 17.
    4. Metabolic Effect -Aspirin uncouples oxidative phosphorylation and reduces lipogenesis - Affects CHO metabolism so that the blood sugar may be elevated or lowered 5. Hepatic and Renal Effects - hepatotoxicity - Reye’s syndrome - Papillary necrosis and interstititial nephritis
  • 18.
    6. Effects onPregnancy - Pregnancy Risk Category: C - Salicylates readily cross placental barrier and are excreted in breast milk - Prolonged gestation, delayed parturition, increased risk of hemorrhage in mother and newborn, increased risk of stillbirth or neonatal death, and decreased birthweight
  • 19.
    7. Hypersensitivity - Resultsfrom inhibition of cyclooxygenase - SRS-A symptoms include bronchospasm, angioneurotic edema, rhinitis, urticaria, wheezing, hypotensive shock, abdominal cramps and nasal polyps 8. Glucose-6-Phosphate Dehydrogenase Deficiency - A common inborn error of metabolism - Symptoms of hemolysis includes abdominal or back pain, anemia, hemoglobinuria
  • 20.
    Toxicity • Salicylism –mild toxic reaction produced by salicylates • Signs and Symptoms: 1. Tinnitus 2. Headache 3. Nausea and vomiting 4. Dizziness 5. Dimness of vision • The lethal adult dose of aspirin is between 10 and 30 gm (30 to 100 of the 5-grain tablets)
  • 21.
    Severe acidosis andelectrolyte imbalance are usually the causes of death resulting from: 1. Depression of the respiratory center (CO2 accumulation) 2. Renal impairment from dehydration and hypotension (inorganic & metabolic acids accumulate) 3. Impaired CHO metabolism that increases the production of metabolic acids
  • 22.
    When aspirin isprescribed for a child, one should ensure that: 1. The dosage is accurately determined 2. Adequate fluid intake is maintained 3. The parent is cognizant of the dangers of poisoning 4. The child does not have chicken pox or flu.
  • 23.
    Treatment: 1. By inducingemesis, gastric lavage, or by the administration of activated charcoal. 2. Severe toxic reaction require immediate hospitalization and the use of IV fluids to correct acidosis and electrolyte imbalance 3. Bathing in tepid water and IV fluid must be promptly administered in case of hyperthermia and dehydration. 4. Alkaline diuresis should be maintained by the administration of sodium bicarbonate 5. Hypoglycemia and hypokalemia are treated symptomatically.
  • 24.
    DRUG INTERACTIONS 1. Warfarin(Coumadin) - oral anticoagulants - aspirin displaces warfarin from plasma protein binding sites which increases active warfarin in the blood and amplifies its toxic effect - administering salicylates to patients can increase prothrombin time and promote GIT bleeding and hemorrhage
  • 25.
    2. Probenecid &Sulfinpyrazone - used in treatment of gout - aspirin has been reported to precipitate an acute attack of gout 3. Sulfonylureas - used in the treatment of adult- onset diabetes mellitus - Aspirins may enhance the hypoglycemic response to sulfonylureas
  • 26.
    4. Methotrexate - usedas a cancer chemotherapy agent or in the treatment of psoriasis - Methotrexate can be displaced from its plasma protein binding sites, leading to an increased concentration of free methotrexate
  • 27.
    Administration, Absorption & Metabolism -Aspirin is almost always administered orally - It is rapidly absorbed, partly from the stomach but mainly from the small intestine - Once absorbed, aspirin is rapidly hydrolyzed in the plasma to salicylic acid which becomes unevenly distributed throughout the body.
  • 28.
    Administration, Absorption & Metabolism -Relatively high concentration are found in the lungs, liver, saliva and kidney; lower levels attained in the muscle and brain - Salicylates are excreted through urine. Very little salicylate is excreted in the feces
  • 29.
    Dosages: Arthritis Adult: PO 2.6-5.2g/day in divided doses q4- 6h Child: PO 90-130 mg/kg/day in divided doses q4-6h Pain/fever Adult: PO/REC 325-650 mg q4h prn, not to exceed 4 g/day Child: PO/REC 40-100 mg/kg/day in divided doses q4-6h prn
  • 30.
    Dosages: Thromboembolic disorders Adult: PO325-650 mg/day or bid Pain/fever Adult: PO 650 mg bid or 325 mg qid; lower daily doses of 160-325 mg have been used as well
  • 31.
    Preparations: 1. Regular aspirin 2.Enteric-coated aspirin 3. Sustained-release aspirin 4. Combinations a. With antacid-buffering agent b.With another analgesic c. With sedatives or antihistamines d.With caffeine
  • 32.
    Diflunisal (Dolobid) - long-actingNSAIA salicylate - Food decrease the rate but not the extent of absorption - Half-life is 8-12 hours; onset 15-30 min; peak 2-3 hr - Metabolized by the liver and excreted via the kidney - Excreted in breast milk, crosses placenta
  • 33.
    Dosage: Pain/fever Adult: PO loadingdose 1 g then 500-1000 mg/day in 2 divided doses, q12h, not to exceed 1500 mg/day
  • 34.
    Adverse effects GI: Nausea,anorexia, vomiting, bleeding, diarrhea, heartburn, anorexia CNS: stimulation, drowsiness, dizziness, confusion, convulsion, headache, flushing, hallucinations, coma CV: rapid pulse, pulmonary edema INTEG: rash, urticaria, bruising ORAL: Dry mouth HEMA: thrombocytopenia, agranulocytosis, hemolytic anemia, increased pro-time RESP: wheezing, hyperpnea ENDO: Hypoglycemia, hyponatremia, hypokalemia
  • 35.
    Contraindications • Hypersensitivity tosalicylates • Bleeding disorders • Children <3 yr • Vit.K deficiency Precautions • Anemia, hepatic disease, renal disease, Hodgkin’s disease, pregnancy category C, lactation
  • 36.
    Drug Interactions GI ulceration,bleeding: aspirin, steroids, alcohol, indomethacin and other NSAIDs Hepatotoxicity, Nephrotoxicity: acetaminophen (prolonged use)
  • 38.
    Mechanism of Action •NSAIAs inhibit the enzyme cyclooxygenase, resulting in a reduction in the formation of prostaglandin precursors and thromboxanes from arachidonic acid.
  • 39.
    Chemical classifications: 1. PropionicAcid Derivatives (Ibuprofen, Fenoprofen, Suprofen, Naproxen, Naproxen sodium, Ketoprofen, Benoxaprofen) 2. Acetic Acid Derivatives (Indomethacin, Sulindac, Tolmetin) 3. Fenamic Acid Derivatives (Meclofenemate, Mefenamic acid) 4. Pyrazolones (Phenylbutazone, Oxyphenbutazone) 5. Oxicams (Piroxicam) 6. Salicylates (Diflunisal)
  • 40.
    Pharmacokinetics: • The NSAIAspeak in usually 1 to 2 hours • They are metabolized in the liver and excreted by the kidney. • Fecal excretion occurs with fenamic acids, piroxicam, sulindac, and tolmetin. • Food can reduce the rate of absorption but oral antacids have minimal or no effect on the rate of absorption
  • 41.
    Uses: • Osteoarthritis, rheumatoid arthritis,gouty arthritis • Fever • Dysmenorrhea • pain
  • 42.
    Pharmacologic effects: 1. Analgesic 2.Antipyretic 3. Antiinflammatory 4. Antigout 5. Dysmenorrhea
  • 43.
    Adverse effects: 1. GITeffects - pain - bleeding leading to tarry stools - irritation - ulceration
  • 44.
    Adverse effects: 2. Renaleffects - renal failure - cystitis - increased incidence of UTI - decreased renal blood flow and glomerular filtration rate in patients with kidney disease
  • 45.
    Adverse effects: 3. CNSeffects - sedation - dizziness - confusion - mental depression - headache - vertigo - convulsions
  • 46.
    Adverse effects: 4. BloodClotting - inhibition of platelet aggregation remains only as long as the drug is present in the blood 5. Other effects - muscle weakness, ringing ears, blurred vision - ulcerative stomatitis, gingival ulceration
  • 47.
    Adverse effects: 6. Hypersensitivity -hives or itching - angioneuretic edema - chills and fever - Steven Johnson syndrome - exfoliative dermatitis - anaphylactoid reactions during bronchospasm
  • 48.
    Adverse effects: 7. Pregnancyand Nursing - prolonged gestation - delayed parturition - dystocia or premature closure of the ductus arteriosus - most NSAIDs are exreted in breastmilk; piroxicam has been shown to inhibit lactation
  • 49.
    Contraindications: • Asthma • Cardiovasculardiseases with fluid retention • Coagulopathies • Peptic ulcer • Ulcerative colitis • Renal function impairment • Hypersensitivity • Geriatric patients
  • 50.
    Ibuprofen • The oldestmember of the NSAIAs and has the most clinical experience • Rapidly absorbed orally, and food decreases absorption, antacids have no effect • Undergoes hepatic metabolism end excreted by the kidney • Peak=1-2 hr; Half-life=2-4 hr; Duration=4-6 hr
  • 51.
    Uses: • Rheumatoid arthritis,osteoarthritis • Primary dysmenorrhea • Gout • Mild-to-moderate pain • fever
  • 52.
    Adverse effects Oral: Drymouth, bleeding, stomatitis GI: Nausea, anorexia, vomiting, diarrhea, jaundice, cholestatic hepatitis, constipation, flatulence, peptic ulcer CNS: Dizziness, drowsiness, fatigue, tremors, confusion, insomnia, anxiety, depression CV: tachycardia, peripheral edema, palpitation, dysrhythmias GU: Nephrotoxicity: dysuria, hematuria, oliguria, azotemia HEMA: Blood dyscrasias
  • 53.
    Contraindications • Hypersensitivity • Asthma •Severe renal disease • Severe hepatic disease Precautions • Pregnancy category not established, lactation, children, bleeding disorders, GI disorders, cardiac disorders, hypersensitivity to other antiinflammatory agents
  • 54.
    Drug Interactions GI ulceration,bleeding: aspirin, alcohol, corticosteroids Decreased action of ibuprofen: salicylates Nephrotoxicity: acetaminophen Risk of increased effects: oral anticoagulants, oral antidiabetics, lithium, methotrexate Decreased antihypertensive effects of: diuretics, B-adrenergic blocker, ACE inhibitors
  • 55.
    Mefenamic acid • Peak=2hr; half-life=3-3 ½ hr • Metabolized in liver, excreted in urine • Excreted in breastmilk • Uses include mild-to-moderate pain, dysmenorrhea, inflammatory disease
  • 56.
    Adverse effects GI: Nausea,anorexia, vomiting, diarrhea, jaundice, cholestatic hepatitis, constipation, flatulence, cramps, peptic ulcer CNS: Dizziness, drowsiness, fatigue, tremors, confusion, insomnia, anxiety, depression CV: tachycardia, peripheral edema, palpitation, dysrhythmias INTEG: purpura, rash, pruritus, sweating GU: Nephrotoxicity: dysuria, hematuria, oliguria, azotemia HEMA: Blood dyscrasias
  • 57.
    Contraindications • Hypersensitivity • Asthma •Severe renal disease • Severe hepatic disease Precautions • Pregnancy category C (avoid prescribing for dental use in last trimester), lactation, children, bleeding disorders, GI disorders, cardiac disorders, hypersensitivity to other antiinflammatory agents
  • 58.
    Drug Interactions GI ulceration,bleeding: aspirin, alcohol, corticosteroids Nephrotoxicity: acetaminophen Risk of increased effects: oral anticoagulants, oral antidiabetics, lithium, methotrexate Decreased antihypertensive effects of: diuretics
  • 60.
    Acetaminophen (Paracetamol; N-acetyl paraaminophenol) •Para-aminophenol derivative from acetanilid • Metabolized in liver, excreted by the kidneys • Crosses the placenta and is also found in breast milk • Rapidly and completely absorbed in the GIT: onset 10-30 min, peak ½- 2hr, duration 4-6 hr, half-life 1-3 hr
  • 61.
    Uses: • Mild-to-moderate pain(inhibition of prostaglandin synthesis in the CNS) • Fever
  • 62.
    Advantages: 1. Therapeutic doseshave no effect on cardiovascular and respiratory system. 2. It does not produce gastric bleeding. 3. It does not affect platelet adhesiveness or affect uric acid excretion. 4. It enhances water transport in kidney.
  • 63.
    Adverse effects: 1. Hepaticnecrosis - may occur in adults after ingestion of a single dose of 10-15 gm acetaminophen - symptoms include N & V, anorexia, and abdominal pain
  • 64.
    Treatment: 1. Ingestion ofgastric lavage 2. Administration of activated charcoal and magnesium or sodium sulfate solution 3. Administration of N-acetylcysteine to reduce or prevent liver damage 4. Hemodialysis or hemoperfusion may be used if oral acetylcysteine does not improve the patient
  • 65.
    Adverse effects: 2. Nephrotoxicity -associated with long-term consumption - primary lesion appears to be a papillary necrosis with secondary interstitial nephritis
  • 66.
    Contraindications • Hypersensitivity Precautions • Anemia •Hepatic disease • Renal disease • Chronic alcoholism • Pregnancy category B
  • 67.
    Drug Interactions Decreased effectsof acetaminophen: barbiturates Nephrotoxicity: NSAIDs, salicylates (chronic hig dose concurrent use) Buffered acetaminophen: decreased absorption of tetracycline Increased bleeding (Chronic, high doses over 2g/day): oral anticoagulants
  • 68.
    References: • Gage, TommyW. Mosby’s Dental Drug Reference.Mosby-Year Book, Inc. 1994. • Holroyd, Sam V. Clinical Pharmacology in Dental Practice.4th ed. The C.V. Mosby Company. 1988.